These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36793734)

  • 1. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
    Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
    Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
    Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
    Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
    Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
    Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polymorphisms of human leukocyte antigen loci may contribute to the susceptibility and severity of severe aplastic anemia in Chinese patients.
    Wang M; Nie N; Feng S; Shi J; Ge M; Li X; Shao Y; Huang J; Zheng Y
    Hum Immunol; 2014 Aug; 75(8):867-72. PubMed ID: 24979673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
    Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis.
    Liu S; Li Q; Zhang Y; Li Q; Ye B; Wu D; Wu L; Lu H; Ji C
    PLoS One; 2016; 11(9):e0162382. PubMed ID: 27611583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
    Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
    Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans.
    In JW; Lee N; Roh EY; Shin S; Park KU; Song EY
    Hematology; 2017 Apr; 22(3):149-154. PubMed ID: 27702400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
    Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
    Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for acquired aplastic anemia.
    Georges GE; Storb R
    Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia.
    Deyell RJ; Shereck EB; Milner RA; Schultz KR
    Pediatr Hematol Oncol; 2011 Sep; 28(6):469-78. PubMed ID: 21707222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia.
    Betensky M; Babushok D; Roth JJ; Mason PJ; Biegel JA; Busse TM; Li Y; Lind C; Papazoglou A; Monos D; Podsakoff G; Bessler M; Olson TS
    Cancer Genet; 2016; 209(1-2):1-10. PubMed ID: 26702937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of detecting human leukocyte antigen class I allele-lacking leukocytes in aplastic anemia].
    Hosokawa K; Nakao S
    Rinsho Ketsueki; 2022; 63(8):899-905. PubMed ID: 36058861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.
    Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR
    Ann Hematol; 2020 Nov; 99(11):2529-2538. PubMed ID: 32948913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
    Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
    Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.